Galapagos NV - Asset Resilience Ratio

Latest as of March 2026: 86.45%

Galapagos NV (GXEA) has an Asset Resilience Ratio of 86.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Galapagos NV short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€2.92 Billion

≈ $3.41 Billion USD Cash + Short-term Investments

Total Assets

€3.37 Billion

≈ $3.94 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Galapagos NV's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Galapagos NV balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Galapagos NV's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Galapagos NV to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€2.92 Billion	86.45%
Total Liquid Assets	€2.92 Billion	86.45%

Asset Resilience Insights

Very High Liquidity: Galapagos NV maintains exceptional liquid asset reserves at 86.45% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Galapagos NV Industry Peers by Asset Resilience Ratio

Compare Galapagos NV's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Galapagos NV (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Galapagos NV.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	85.43%	€2.91 Billion ≈ $3.40 Billion	€3.41 Billion ≈ $3.98 Billion	+11.60pp
2024-12-31	73.83%	€3.05 Billion ≈ $3.57 Billion	€4.14 Billion ≈ $4.84 Billion	-6.90pp
2023-12-31	80.73%	€3.52 Billion ≈ $4.11 Billion	€4.36 Billion ≈ $5.09 Billion	+4.99pp
2022-12-31	75.74%	€3.59 Billion ≈ $4.19 Billion	€4.73 Billion ≈ $5.53 Billion	+28.18pp
2021-12-31	47.56%	€2.47 Billion ≈ $2.89 Billion	€5.19 Billion ≈ $6.07 Billion	-5.37pp
2020-12-31	52.93%	€3.03 Billion ≈ $3.54 Billion	€5.72 Billion ≈ $6.68 Billion	-11.65pp
2019-12-31	64.58%	€3.92 Billion ≈ $4.58 Billion	€6.07 Billion ≈ $7.09 Billion	--

pp = percentage points

About Galapagos NV

F:GXEA Germany Biotechnology

Market Cap

$1.93 Billion

€1.65 Billion EUR

Market Cap Rank

#7040 Global

#995 in Germany

Share Price

€25.00

Change (1 day)

+4.17%

52-Week Range

€22.40 - €31.40

All Time High

€246.00